The activity of matrix metalloproteinase-9 (MMP-9) is known to be involved in the degradation of the extracellular matrix and basement membrane, and its elevated levels have been associated with cancer progression and reduced patient survival [61]. This evidence concerns the gene MMP9 and cancer.